← Open Payments lookup

DAX WOLFORD: Open Payments

NPI 1851742100 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$25,457 in 124 payments from 13 companies in 2025. Trend: 2023 $1,587 · 2024 $2,019 · 2025 $25,457

Speaker / faculty: $17,280Consulting: $2,970Travel & lodging: $2,877Food & beverage: $2,330
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)67$24,016
Alkermes, Inc.13$414
E.R. Squibb & Sons, L.L.C.14$390
ABBVIE INC.13$287
Otsuka America Pharmaceutical, Inc.4$96
Axsome Therapeutics, Inc.3$60
Teva Pharmaceuticals USA, Inc.3$56
Supernus Pharmaceuticals, Inc.2$29
Vanda Pharmaceuticals Inc.1$29
Bausch Health US, LLC1$25

Products named: CAPLYTA, COBENFY, ARISTADA, VRAYLAR, LYBALVI, Auvelity, REXULTI, ABILIFY ASIMTUFII.

Industry payments across NV — which companies pay providers there.